Medication safety is a crucial issue for ensuring the protection of patients when taking medication and using health products. It aims to minimize the risks associated with adverse effects, medication errors, and any other complications that may arise during the prescribing, dispensing, and administration of medications.

To ensure this safety, it is essential to implement rigorous monitoring and proactive management of adverse events.

This also relies on close collaboration between healthcare professionals, care teams, regional pharmacovigilance centers, and health authorities. Throughout this process, the goal is to provide patients with a reliable environment that minimizes risks and improves the quality of care. This effort is particularly important for vulnerable populations, such as children, who require special attention. Understanding Drug Safety

Definition and Importance

Medication safety encompasses all the measures necessary to ensure that medicines are used safely, effectively, and appropriately. Its main objective is to prevent adverse effects and complications within the medication circuit.

It ensures that each patient receives the right medication, under the right conditions, at the correct dosage, while minimizing the risks associated with medication use. This concept goes far beyond the simple pharmaceutical product. It includes risk management, enhanced monitoring of adverse effects, as well as the training and information of healthcare professionals and patients. In short, medication safety is a key element in guaranteeing the quality of care and preserving public health.

Key Players in Drug Safety

Ensuring the safety of healthcare products relies on collaboration between several essential players. physicians and care teams play a central role by prescribing and administering medications appropriately. They must also ensure that medication errors that could compromise patient safety.

Pharmacists, for their part, actively contribute to pharmacovigilance. They ensure the monitoring and reporting of adverse events, thus guaranteeing rigorous risk management. For its part, the French National Agency for Medicines and Health Products Safety (ANSM) defines and enforces strict standards for the marketing authorization of medicines and medical devices. This ensures the quality and safety of health products. Finally, the patient plays an active role in their own safety. By following the instructions provided and reporting any side effects or suspected risks, they contribute to increased vigilance surrounding medicines. The role of the ANSM in drug safety

Risk Monitoring and Assessment

The French National Agency for Medicines and Health Products Safety (ANSM) plays a key role in the enhanced monitoring of medicines and other health products throughout their lifecycle. It collects, analyzes, and assesses reports related to pharmacovigilance, medication errors, misuse, and adverse events.

This information comes from various sources, including healthcare professionals and patients.

Thanks to this active monitoring, the ANSM can quickly detect any warning signs, assess the benefit/risk balance of products, and take appropriate measures to guarantee patient safety and protect public health.

Marketing Authorization Procedures

The ANSM plays a key role in the marketing authorization of medicines and biological products. Before a product is marketed, the agency conducts a thorough scientific evaluation of its quality, efficacy, and safety. This step ensures that only products compliant with regulatory standards, with an acceptable benefit/risk balance, are accessible to patients. In addition, the ANSM conducts laboratory quality controls and inspects manufacturing sites to verify compliance with good practices. Communication and Management of Health Crises: When a health crisis occurs related to a medicine or health product, the ANSM intervenes quickly to inform healthcare professionals and the public. It publishes recommendations, alerts, and updates on measures to be adopted to limit risks to patients. The ANSM's ability to communicate effectively, coordinate the actions of different stakeholders, and manage emergency situations strengthens the confidence of patients and professionals in the healthcare system. This approach contributes to drug safety. Furthermore, the agency collaborates with European and international organizations to harmonize practices and collectively address public health challenges.

Medication errors: prevention and management

Classifying medication errors

medication errors refer to actions that deviate from good practices and can occur at different stages of the medication circuit: prescription, transcription, dispensing, administration, or monitoring. These errors include dosage errors, incorrect route of administration, administration of the wrong medication, and preparation errors. While some errors are inconsequential, others can lead to serious adverse events, such as worsening of the condition or the development of complications. The classification of errors takes into account their severity and clinical impact on the patient, ranging from a risk avoided to severe consequences, such as a toxic reaction or hospitalization. Medication Error Prevention Strategies: Preventing medication errors relies on implementing robust measures at each stage of the process. Ongoing education for healthcare professionals and awareness of risk management are essential. Computerized tools, such as electronic prescriptions, double-checking systems, and standardized medication lists, play a key role in reducing errors. Furthermore, clear communication among all stakeholders—the physician, pharmacist, healthcare team, and patient—strengthens patient safety. Regular monitoring of medication incidents and systematic analysis of adverse events help identify weaknesses and improve procedures. Incident and Crisis Management: When a medication error is detected, rapid and transparent management is essential. The aim is to assess the impact on the patient, implement immediate corrective measures, and prevent the recurrence of the incident.

Reporting to pharmacovigilance bodies and regional centers allows for a thorough analysis of the causes. In the event of a health crisis, effective coordination between healthcare professionals, authorities, and healthcare facilities is essential to manage the consequences and restore confidence. This proactive approach fosters a safety culture where every error becomes an opportunity for learning and continuous improvement.

ANSM Guide on Drug Safety

Objectives and Targets

The ANSM Guide on Drug Safety aims to strengthen patient safety by providing healthcare professionals with a structured framework for optimal management of medicines and health products. It is intended for physicians, pharmacists, healthcare teams, and all stakeholders involved in the medication supply chain.

Healthcare facilities wishing to improve their practices will also find valuable resources here.

The main objective is to prevent medication errors, to guide enhanced monitoring, and to promote effective interprofessional collaboration around medication-related risk management.

Main Content and Recommendations

The guide highlights several key areas for ensuring safe medication use. Among the recommendations are practical tips regarding the prescribing, dispensing, and administration of medications.

It also emphasizes the importance of reporting adverse events and maintaining active pharmacovigilance. Key points include developing medication lists tailored to the specific needs of patients, such as children, implementing standardized procedures to reduce medication errors, and the importance of clear communication between healthcare professionals and patients. The guide also highlights the need for ongoing training for healthcare professionals and encourages the use of technological tools to further secure the medication circuit. Implementation of the guide: challenges and perspectives. Implementing the ANSM Guide presents a significant organizational challenge and requires strong commitment from healthcare facilities. This implies a collective commitment to making medication safety a shared priority.

The main challenges concern reducing side effects and medication errors, while improving the quality of care and patient confidence. In the medium term, the ANSM plans to integrate more digital tools and automation to simplify the monitoring and evaluation of healthcare products. At the same time, it will continue to promote awareness and collaboration among healthcare professionals.

These perspectives aim to build an increasingly safe, transparent, and efficient healthcare system.

Conclusion

medication safety is a major issue for public health.

It is based on the prevention of medication errors and the effective management of risks associated with medications. The ANSM plays a central role in monitoring and regulating health products, while also providing guidelines and recommendations aimed at improving the quality of care. To guarantee optimal safety, close collaboration between healthcare professionals, patients, and authorities is essential. Together, we can strengthen medication safety and build a more reliable healthcare system.

Let's adopt safe practices today and engage in active collaboration for a future where health is better protected.

FAQ

What are the most common medication errors reported in healthcare settings?

The most common medication errors in healthcare settings include:

• Prescribing errors: such as using a contraindicated medication or the wrong dose.
• Administration errors: the wrong medication or the wrong route of administration.
• Patient identification errors.
• Problems related to storage and hygiene.

These errors can lead to effects serious adverse events, endangering patients' health.

What recommendations does the ANSM propose to ensure the safe administration of oral medications, particularly oral solutions?

The ANSM highlights recommendations aimed at ensuring the safe administration of oral medications, particularly oral solutions. These guidelines include:

• Clear and accurate labeling on packaging.
• Practical advice for prescribers and pharmacists to ensure correct dosages and avoid drug interactions.

These measures help reduce the risk of medication errors.

How can healthcare professionals limit the risk of confusion between different formulations of the same drug, such as trastuzumab?

To avoid confusion between different formulations of trastuzumab, healthcare professionals should:

• Systematically check the name, form, route of administration, and dosage on the label and prescription.
• Implement strict protocols and perform double-checking.
• Ensure clear communication with the patient or caregiver.

These practices are essential to ensure safe administration.

Which administration devices are covered by the ANSM recommendations to prevent medication errors?

The ANSM recommendations primarily target administration devices for oral solutions, such as:

• Dosing syringes.
• Graduated cups.
• Dosing spoons.

These devices help limit dosage or administration errors, whether in children, adults, or the elderly.